The safety assessment of medical devices in China involves rigorous evaluation during the registration process, including compliance with international standards, clinical evaluations, and risk management. After NMPA certification, ongoing safety review strategies are implemented through post-market surveillance, vigilance reporting, and compliance with regulatory requirements. Effective post-market monitoring, timely updates to technical documentation, and proactive safety communication are crucial for ensuring the continued safety and effectiveness of medical devices in the Chinese market.